InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Rajangam Kanya, Directeur Médical. Officer active across 2 companies, notably Nkarta, Inc.. In total, 8 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €5k. Activity tracked since 5 August 2021. The latest transaction was disclosed on 9 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Rajangam Kanya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
10,757 shares0Common StockSEC:0001628280-26-016795:0
1,384 shares0Common StockSEC:0001628280-26-005018:0
33,000 shares@ US$2.2593.0% of flowCommon StockSEC:0001854270-25-000034:0
78,363 shares0Common StockSEC:0001854270-25-000015:0
1,297 shares@ US$4.077.0% of flowCommon StockSEC:0001854270-25-000002:0
101,000 shares0Common StockSEC:0001854270-24-000017:0
12,800 shares0Common StockSEC:0001209191-22-003756:0
10,000 shares@ US$0.41100.0% of flowCommon StockSEC:0000899243-21-032196:0
8 of 8 declarations
About Rajangam Kanya
Rajangam Kanya is Directeur Médical. He has 8 filings in total, and across the 8 sampled filings the transactions are mainly attributions, with EUR 5,111 of sales, over the period from 2021-08-09 to 2026-03-11. He is associated with Senti Biosciences, Inc. and Nkarta, Inc.
